Neurological Disorder Diagnostics Global Market Report 2025

Global Neurological Disorder Diagnostics Market Report 2024

Neurological Disorder Diagnostics Global Market Report 2025 – By Component (Instruments, Reagents, Kits, Software, Services), By Technology (Immunoassay, Polymerase Chain Reaction (PCR) Techniques), By Disease Type (Alzheimer's Disease, Dementia, Parkinson's Disease, Epilepsy, Traumatic Brain Injury, Other Disease Types), By End User (Hospitals And Clinics, Diagnostic Centers, Academic And Research Institutes) – Market Size, Trends, And Global Forecast 2025-2034

Name: Neurological Disorder Diagnostics Global Market Report 2025
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Neurological Disorder Diagnostics Global Market Report 2025

Report Price : $4490.00 | Pages : 175 | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Neurological Disorder Diagnostics Global Market Report 2025

Proud Members Of

Neurological Disorder Diagnostics Market Definition

Neurological disorder diagnostics refer to the various methods and technologies used to identify, assess, and monitor diseases affecting the nervous system, including the brain, spinal cord, and nerves. These diagnostics involve advanced imaging techniques, biomarker analysis, genetic testing, and cognitive assessments to detect abnormalities, determine disease presence and progression, and guide treatment strategies for neurological conditions.

The main components in the neurological disorder diagnostics market are instruments, reagents, kits, software, and services. Instruments refer to the physical devices used in diagnosing neurological disorders. The various technologies include immunoassay and polymerase chain reaction (PCR) techniques, and several types of diseases including Alzheimer’s disease, dementia, Parkinson’s disease, epilepsy, traumatic brain injury, and others. The different end users encompass hospitals and clinics, diagnostic centers, and academic and research institutes.

Neurological Disorder Diagnostics Market Segmentation

The neurological disorder diagnosticsmarket covered in this report is segmented –

1) By Component: Instruments, Reagents, Kits, Software, Services

2) By Technology: Immunoassay, Polymerase Chain Reaction (PCR) Techniques

3) By Disease Type: Alzheimer's Disease, Dementia, Parkinson's Disease, Epilepsy, Traumatic Brain Injury, Other Disease Types

4) By End User: Hospitals And Clinics, Diagnostic Centers, Academic And Research Institutes

Subsegments:

1) By Instruments: Electroencephalography (EEG) Machines, Magnetic Resonance Imaging (MRI) Machines, Computed Tomography (CT) Scanners, Positron Emission Tomography (PET) Scanners, Lumbar Puncture Equipment, Ultrasound Devices, Neurostimulation Devices, Transcranial Magnetic Stimulation (TMS) Devices,

2) By Reagents: Biochemical Reagents, Antibodies, DNA Probes, RNA Probes, Enzyme-linked Immunosorbent Assay (ELISA) Reagents, Polymerase Chain Reaction (PCR) Reagents, Sample Collection Reagents

3) By Kits: Diagnostic Test Kits, Genetic Testing Kits, Biomarker Detection Kits, Immunoassay Kits, Point-of-Care Testing Kits, Screening Kits for Neurological Disorders

4) By Software: Diagnostic Software for Imaging Analysis, Data Management Software, Clinical Decision Support Software, Patient Management Software, Laboratory Information Management Systems (LIMS), Neuroinformatics Software, Telemedicine Software

5) By Services: Diagnostic Testing Services, Consultation Services, Training and Support Services, Maintenance and Repair Services for Equipment, Telehealth Services, Data Analysis Services, Research and Development Services

Neurological Disorder Diagnostics Market Size and growth rate 2025 to 2029: Graph

Neurological Disorder Diagnostics Market Size 2025 And Growth Rate

The neurological disorder diagnostics market size has grown strongly in recent years. It will grow from $11.75 billion in 2024 to $12.61 billion in 2025 at a compound annual growth rate (CAGR) of 7.3%. The growth in the historic period can be attributed to increase in prevalence of neurological disorders, increase in ageing population, growth in emphasis on early diagnosis and disease management, growth in awareness of neurological disorders, and increase focus on early diagnosis.

Neurological Disorder Diagnostics Market Growth Forecast

The neurological disorder diagnostics market size is expected to see strong growth in the next few years. It will grow to $16.6 billion in 2029 at a compound annual growth rate (CAGR) of 7.1%. The growth in the forecast period can be attributed to growing awareness and education, increasing healthcare expenditure, improved access to healthcare services, expansion of diagnostic centers, and rising adoption of personalized medicine. Major trends in the forecast period include advancements in neuroimaging techniques, adoption of wearable devices and remote monitoring technologies, advancements in biomarker discovery and genetic testing, integration of artificial intelligence and machine learning, and development of point-of-care diagnostic devices.

Book your 30 minutes free consultation with our research experts

Neurological Disorder Diagnostics Market Driver: Rising Alzheimer's Prevalence Fuels Growth in Neurological Disorder Diagnostics Market

The increasing prevalence of Alzheimer's disease is expected to propel the growth of the neurological disorder diagnostics market going forward. Alzheimer's disease refers to a progressive neurodegenerative disorder characterized by a gradual decline in cognitive functions, including memory, reasoning, and problem-solving. Alzheimer's disease combines genetic factors, such as specific gene mutations and variations, the accumulation of amyloid plaques and tau tangles in the brain, chronic inflammation, vascular issues, and lifestyle factors. Neurological disorder diagnostics help Alzheimer's disease by enabling early and accurate detection through advanced imaging techniques, biomarker analysis, and cognitive assessments. For instance, in September 2024, according to the Australian Institute of Health and Welfare, an Australia-based government agency, in 2023, approximately 411,100 individuals in Australia were living with dementia, including around 257,500 women and 153,700 men. Thus, the increasing prevalence of Alzheimer's disease is driving the growth of the neurological disorder diagnostics market.

Global Neurological Disorder Diagnostics Market Major Players

Major companies operating in the neurological disorder diagnostics market are Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Novartis AG, Medtronic plc, Amgen Inc., Siemens Healthineers AG, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Otsuka Pharmaceutical Co. Ltd., Boston Scientific Corporation, Neurocrine Biosciences Inc., Neusoft Medical Systems Co. Ltd., Nihon Kohden Corporation, Natus Medical Incorporated, Esaote S.p.A, Canon Medical Systems Corporation, NeuroPace Inc., Lifelines Neuro Company LLC, York Instruments Ltd., Advanced Brain Monitoring Inc., Neurometrix Inc., Croton Healthcare Private Limited, NeuroLogica Corporation

Global Neurological Disorder Diagnostics Market Trend: Innovative Neurological Disease Quantification Software Transforming Diagnostics Worldwide

Major companies operating in the neurological disorder diagnostics market are focused on developing innovative solutions, such as neurological disease quantification software, for one billion individuals affected by neurological diseases worldwide. Neurological disease quantification software is a tool used to measure and analyze brain function and disease progression in neurological conditions. For instance, in January 2024, Quibim, a Spain-based biotechnology company, launched the QP-Brain, an AI-based early-stage neurological disease quantification software. QP-Brain by Quibim is advanced neuroimaging analysis software designed to quantify brain tissue alterations in neurological diseases. Its unique features include AI-powered automated segmentation and detailed volumetric analysis, offering precise insights into brain structure changes for clinical and research applications.

Neurological Disorder Diagnostics Market Merger And Acquisition: Lantheus Acquires Cerveau Technologies to Enhance Alzheimer's Imaging Capabilities

In February 2023, Lantheus, a US-based pharmaceutical manufacturing company, acquired Cerveau Technologies for an undisclosed amount. Lantheus' acquisition of Cerveau and its tau-targeting PET imaging agent MK-6240 significantly enhances the ability to diagnose, stage, and monitor Alzheimer's disease while supporting the development of new treatments. Cerveau Technologies is a US-based company specializing in developing diagnostic technologies for neurological disorders, mainly focusing on neurodegenerative diseases such as Alzheimer's.

Regional Outlook For The Global Neurological Disorder Diagnostics Market

North America was the largest region in the neurological disorder diagnostics market in 2024. The regions covered in the neurological disorder diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the neurological disorder diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Neurological Disorder Diagnostics Market?

The neurological disorder diagnostics market consists of revenues earned by entities by providing services such as neuroimaging, electrophysiological testing, genetic analysis, cerebrospinal fluid examination, neuropsychological assessments, and laboratory tests. The market value includes the value of related goods sold by the service provider or included within the service offering. The neurological disorder diagnostics market also includes sales of imaging devices, biomarker tests, and cognitive assessment tools. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Neurological Disorder Diagnostics Industry?

The neurological disorder diagnostics market research report is one of a series of new reports from The Business Research Company that provides neurological disorder diagnostics market statistics, including the neurological disorder diagnostics industry global market size, regional shares, competitors with neurological disorder diagnostics market share, detailed neurological disorder diagnostics market segments, market trends, and opportunities, and any further data you may need to thrive in the neurological disorder diagnostics industry. These neurological disorder diagnostics market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Neurological Disorder Diagnostics Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$12.61 billion
Revenue Forecast In 2034	$16.6 billion
Growth Rate	CAGR of 7.1% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	1) By Component: Instruments, Reagents, Kits, Software, Services 2) By Technology: Immunoassay, Polymerase Chain Reaction (PCR) Techniques 3) By Disease Type: Alzheimer's Disease, Dementia, Parkinson's Disease, Epilepsy, Traumatic Brain Injury, Other Disease Types 4) By End User: Hospitals And Clinics, Diagnostic Centers, Academic And Research Institutes Subsegments: 1) By Instruments: Electroencephalography (EEG) Machines, Magnetic Resonance Imaging (MRI) Machines, Computed Tomography (CT) Scanners, Positron Emission Tomography (PET) Scanners, Lumbar Puncture Equipment, Ultrasound Devices, Neurostimulation Devices, Transcranial Magnetic Stimulation (TMS) Devices, 2) By Reagents: Biochemical Reagents, Antibodies, DNA Probes, RNA Probes, Enzyme-linked Immunosorbent Assay (ELISA) Reagents, Polymerase Chain Reaction (PCR) Reagents, Sample Collection Reagents 3) By Kits: Diagnostic Test Kits, Genetic Testing Kits, Biomarker Detection Kits, Immunoassay Kits, Point-of-Care Testing Kits, Screening Kits for Neurological Disorders 4) By Software: Diagnostic Software for Imaging Analysis, Data Management Software, Clinical Decision Support Software, Patient Management Software, Laboratory Information Management Systems (LIMS), Neuroinformatics Software, Telemedicine Software 5) By Services: Diagnostic Testing Services, Consultation Services, Training and Support Services, Maintenance and Repair Services for Equipment, Telehealth Services, Data Analysis Services, Research and Development Services
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Novartis AG, Medtronic plc, Amgen Inc., Siemens Healthineers AG, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Otsuka Pharmaceutical Co. Ltd., Boston Scientific Corporation, Neurocrine Biosciences Inc., Neusoft Medical Systems Co.Ltd., Nihon Kohden Corporation, Natus Medical Incorporated, Esaote S.p.A, Canon Medical Systems Corporation, NeuroPace Inc., Lifelines Neuro Company LLC, York Instruments Ltd., Advanced Brain Monitoring Inc., Neurometrix Inc., Croton Healthcare Private Limited, NeuroLogica Corporation
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Neurological Disorder Diagnostics Market Characteristics

3. Neurological Disorder Diagnostics Market Trends And Strategies

4. Neurological Disorder Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Neurological Disorder Diagnostics Growth Analysis And Strategic Analysis Framework

5.1. Global Neurological Disorder Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Neurological Disorder Diagnostics Market Growth Rate Analysis

5.4. Global Neurological Disorder Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Neurological Disorder Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Neurological Disorder Diagnostics Total Addressable Market (TAM)

6. Neurological Disorder Diagnostics Market Segmentation

6.1. Global Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Instruments

Reagents

Kits

Software

Services

6.2. Global Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Immunoassay

Polymerase Chain Reaction (PCR) Techniques

6.3. Global Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Alzheimer's Disease

Dementia

Parkinson's Disease

Epilepsy

Traumatic Brain Injury

Other Disease Types

6.4. Global Neurological Disorder Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals And Clinics

Diagnostic Centers

Academic And Research Institutes

6.5. Global Neurological Disorder Diagnostics Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Electroencephalography (EEG) Machines

Magnetic Resonance Imaging (MRI) Machines

Computed Tomography (CT) Scanners

Positron Emission Tomography (PET) Scanners

Lumbar Puncture Equipment

Ultrasound Devices

Neurostimulation Devices

Transcranial Magnetic Stimulation (TMS) Devices

6.6. Global Neurological Disorder Diagnostics Market, Sub-Segmentation Of Reagents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Biochemical Reagents

Antibodies

DNA Probes

RNA Probes

Enzyme-linked Immunosorbent Assay (ELISA) Reagents

Polymerase Chain Reaction (PCR) Reagents

Sample Collection Reagents

6.7. Global Neurological Disorder Diagnostics Market, Sub-Segmentation Of Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Diagnostic Test Kits

Genetic Testing Kits

Biomarker Detection Kits

Immunoassay Kits

Point-of-Care Testing Kits

Screening Kits for Neurological Disorders

6.8. Global Neurological Disorder Diagnostics Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Diagnostic Software for Imaging Analysis

Data Management Software

Clinical Decision Support Software

Patient Management Software

Laboratory Information Management Systems (LIMS)

Neuroinformatics Software

Telemedicine Software

6.9. Global Neurological Disorder Diagnostics Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Diagnostic Testing Services

Consultation Services

Training and Support Services

Maintenance and Repair Services for Equipment

Telehealth Services

Data Analysis Services

Research and Development Services

7. Neurological Disorder Diagnostics Market Regional And Country Analysis

7.1. Global Neurological Disorder Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Neurological Disorder Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Neurological Disorder Diagnostics Market

8.1. Asia-Pacific Neurological Disorder Diagnostics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Neurological Disorder Diagnostics Market

9.1. China Neurological Disorder Diagnostics Market Overview

9.2. China Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Neurological Disorder Diagnostics Market

10.1. India Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Neurological Disorder Diagnostics Market

11.1. Japan Neurological Disorder Diagnostics Market Overview

11.2. Japan Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Neurological Disorder Diagnostics Market

12.1. Australia Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Neurological Disorder Diagnostics Market

13.1. Indonesia Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Neurological Disorder Diagnostics Market

14.1. South Korea Neurological Disorder Diagnostics Market Overview

14.2. South Korea Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Neurological Disorder Diagnostics Market

15.1. Western Europe Neurological Disorder Diagnostics Market Overview

15.2. Western Europe Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Neurological Disorder Diagnostics Market

16.1. UK Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Neurological Disorder Diagnostics Market

17.1. Germany Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Neurological Disorder Diagnostics Market

18.1. France Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Neurological Disorder Diagnostics Market

19.1. Italy Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Neurological Disorder Diagnostics Market

20.1. Spain Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Neurological Disorder Diagnostics Market

21.1. Eastern Europe Neurological Disorder Diagnostics Market Overview

21.2. Eastern Europe Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Neurological Disorder Diagnostics Market

22.1. Russia Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Neurological Disorder Diagnostics Market

23.1. North America Neurological Disorder Diagnostics Market Overview

23.2. North America Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Neurological Disorder Diagnostics Market

24.1. USA Neurological Disorder Diagnostics Market Overview

24.2. USA Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Neurological Disorder Diagnostics Market

25.1. Canada Neurological Disorder Diagnostics Market Overview

25.2. Canada Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Neurological Disorder Diagnostics Market

26.1. South America Neurological Disorder Diagnostics Market Overview

26.2. South America Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Neurological Disorder Diagnostics Market

27.1. Brazil Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Neurological Disorder Diagnostics Market

28.1. Middle East Neurological Disorder Diagnostics Market Overview

28.2. Middle East Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Neurological Disorder Diagnostics Market

29.1. Africa Neurological Disorder Diagnostics Market Overview

29.2. Africa Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Neurological Disorder Diagnostics Market Competitive Landscape And Company Profiles

30.1. Neurological Disorder Diagnostics Market Competitive Landscape

30.2. Neurological Disorder Diagnostics Market Company Profiles

30.2.1. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

31. Neurological Disorder Diagnostics Market Other Major And Innovative Companies

31.1. Medtronic plc

31.2. Amgen Inc.

31.3. Siemens Healthineers AG

31.4. Koninklijke Philips N.V.

31.5. GE HealthCare Technologies Inc.

31.6. Otsuka Pharmaceutical Co. Ltd.

31.7. Boston Scientific Corporation

31.8. Neurocrine Biosciences Inc.

31.9. Neusoft Medical Systems Co.Ltd.

31.10. Nihon Kohden Corporation

31.11. Natus Medical Incorporated

31.12. Esaote S.p.A

31.13. Canon Medical Systems Corporation

31.14. NeuroPace Inc.

31.15. Lifelines Neuro Company LLC

32. Global Neurological Disorder Diagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Neurological Disorder Diagnostics Market

34. Recent Developments In The Neurological Disorder Diagnostics Market

35. Neurological Disorder Diagnostics Market High Potential Countries, Segments and Strategies

35.1 Neurological Disorder Diagnostics Market In 2029 - Countries Offering Most New Opportunities

35.2 Neurological Disorder Diagnostics Market In 2029 - Segments Offering Most New Opportunities

35.3 Neurological Disorder Diagnostics Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Neurological Disorder Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Neurological Disorder Diagnostics Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Neurological Disorder Diagnostics Market, Sub-Segmentation Of Reagents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Neurological Disorder Diagnostics Market, Sub-Segmentation Of Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Neurological Disorder Diagnostics Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global Neurological Disorder Diagnostics Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Global Neurological Disorder Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Global Neurological Disorder Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Asia-Pacific, Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: Asia-Pacific, Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: Asia-Pacific, Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: China, Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: China, Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: China, Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: India, Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: India, Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: India, Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Japan, Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Japan, Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Japan, Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Australia, Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Australia, Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Australia, Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Indonesia, Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: Indonesia, Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: Indonesia, Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: South Korea, Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: South Korea, Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: South Korea, Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: Western Europe, Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: Western Europe, Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: Western Europe, Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: UK, Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: UK, Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: UK, Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: Germany, Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: Germany, Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: Germany, Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: France, Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: France, Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: France, Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Italy, Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Italy, Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Italy, Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Spain, Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Spain, Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Spain, Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Eastern Europe, Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Eastern Europe, Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Eastern Europe, Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Russia, Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: Russia, Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: Russia, Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: North America, Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: North America, Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: North America, Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: USA, Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: USA, Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: USA, Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: Canada, Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: Canada, Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: Canada, Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: South America, Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: South America, Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: South America, Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Brazil, Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Brazil, Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Brazil, Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Middle East, Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Middle East, Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Middle East, Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Africa, Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: Africa, Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 79: Africa, Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 80: Johnson & Johnson Services Inc. Financial Performance

Table 81: F. Hoffmann-La Roche Ltd Financial Performance

Table 82: Thermo Fisher Scientific Inc. Financial Performance

Table 83: Abbott Laboratories Financial Performance

Table 84: Novartis AG Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Neurological Disorder Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Neurological Disorder Diagnostics Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Neurological Disorder Diagnostics Market, Sub-Segmentation Of Reagents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Neurological Disorder Diagnostics Market, Sub-Segmentation Of Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Neurological Disorder Diagnostics Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global Neurological Disorder Diagnostics Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Global Neurological Disorder Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Global Neurological Disorder Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Asia-Pacific, Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: Asia-Pacific, Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: Asia-Pacific, Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: China, Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: China, Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: China, Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: India, Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: India, Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: India, Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Japan, Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Japan, Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Japan, Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Australia, Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Australia, Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Australia, Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Indonesia, Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: Indonesia, Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: Indonesia, Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: South Korea, Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: South Korea, Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: South Korea, Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: Western Europe, Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: Western Europe, Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: Western Europe, Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: UK, Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: UK, Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: UK, Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: Germany, Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: Germany, Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: Germany, Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: France, Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: France, Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: France, Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Italy, Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Italy, Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Italy, Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Spain, Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Spain, Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Spain, Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Eastern Europe, Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Eastern Europe, Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Eastern Europe, Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Russia, Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: Russia, Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: Russia, Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: North America, Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: North America, Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: North America, Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: USA, Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: USA, Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: USA, Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: Canada, Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: Canada, Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: Canada, Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: South America, Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: South America, Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: South America, Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Brazil, Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Brazil, Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Brazil, Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Middle East, Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Middle East, Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Middle East, Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Africa, Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: Africa, Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 79: Africa, Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 80: Johnson & Johnson Services Inc. Financial Performance

Figure 81: F. Hoffmann-La Roche Ltd Financial Performance

Figure 82: Thermo Fisher Scientific Inc. Financial Performance

Figure 83: Abbott Laboratories Financial Performance

Figure 84: Novartis AG Financial Performance

Forecasting Till 2030: Opportunities And Strategies In The Global Value Based Care Payment Market – Includes Value Based Care Payment Market Analysis

How Will The Nuclear Medicine Market Grow In 2022?

What Is The Pediatric Imaging Market Overview In 2022?

Latest Healthcare Technology Management Market Growth Study 2022-2026 By The Business Research Company

The Business Research Company offers the hospital acquired infection control market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the multiplex assays market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the healthcare it consulting market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the renal biomarkers market research report 2022 with industry size, share, segments and market growth

Neurology Devices Global Market Report 2025 – By Type (Cerebrospinal Fluid Management (CSF) Devices And Equipment, Interventional Neurology Devices And Equipment, Neurosurgery Devices And Equipment, Neurostimulation Device), By Type of Expenditure (Public, Private), By Product (Instruments/Equipment, Disposables), By End User (Hospitals And Clinics, Diagnostic Laboratories, Other End Users) – Market Size, Trends, And Global Forecast 2025-203

View Report

Interventional Neurology Devices And Equipment Global Market Report 2025 – By Type (Aneurysm Coiling & Embolization Devices, Cerebrospinal Fluid Management Devices, Neurothrombectomy Devices, Support Devices), Aneurysm Coiling & Embolization Devices By Type (Embolic coils, Flow diversion devices, Liquid embolic devices), Angioplasty Devices by Type (Carotid artery stents, Embolic protection systems), Support Devices By Type, Micro guide wires, Micro catheters), Neurothrombectomy Devices By Type (CLOT retrieval devices, Suction and aspiration devices, Snare), By End-User (Hospitals, Neurology clinics, Ambulatory care centers and others) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Neuroprosthetics Global Market Report 2025 – By Type (Motor Neuroprosthetics, Auditory Neuroprosthetics/ Cochlear implants, Visual Neuroprosthetics/ Retinal implants, Cognitive Neuroprosthetics ), By Technique (Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation, Transcranial Magnetic Stimulation ), By Application (Motor Neuron Disorders, Physiological Disorders, Cognitive Disorders ) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Neuroscience Antibodies & Assays Global Market Report 2025 – By Product (Consumables, Instruments ), By Technology (Molecular Diagnostics, Clinical Chemistry, Immunoassays Or Immunochemistry, Others Technologies ), By Application (In Vitro Diagnostics, Research, Drug Discovery ), By End User (Hospitals And Diagnostics Centers, Academic And Research Institutes, Pharmaceutical And Biotechnology Companies) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Neuroscience Global Market Report 2025 – By Type( Neuro-Microscopy, Electrophysiology Technologies, Neuro-Cellular Manipulation, Whole Brain Imaging, Other Types), By Service( Instruments And Consumables, Software And Services), By End User( Hospitals, Diagnostic Labs, Research And Academic Institutes) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Intraoperative Neuromonitoring Global Market Report 2025 – By Products and Services( Systems, Accessories, Services), By Modality( Motor Evoked Potentials, Somatosensory Evoked Potentials, Electroencephalography, Electromyography, Brainstem Auditory Evoked Potentials, Visual Evoked Potentials), By Application( Spinal Surgery, Neurosurgery, Vascular Surgery, ENT Surgery, Orthopedic Surgery, Other Surgeries), By End User( Hospitals, Ambulatory Surgical centers) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Diabetic Neuropathy Global Market Report 2025 – By Disorder (Peripheral Neuropathy, Autonomic Neuropathy, Proximal Neuropathy, Focal Neuropathy), By Drug Class (Analgesics, Anti-Depressants, Anti-convulsant, Other Drug Classes), By Treatment (Drug Treatment, Radiotherapy, Physiotherapy, Other Treatments), By Distribution Channel (Online Distribution, Offline Distribution), By End-user (Hospitals, Specialty Clinics, Other End-users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Neurotechnology Global Market Report 2025 – By Conditions (Cognitive Disorders, Pain Treatment, Urinary And Faecal Incontinence, Epilepsy, Parkinson's Disease, Hearing Conditions, Sleep Disorder, Depression, Other Conditions), By Type (Imaging Modalities, Neurostimulation, Cranial Surface Measurement, Neurological Implants, Other Types), By End Use (Ambulatory Surgical Centers, Hospitals, Homecare Facilities, Other End Uses) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the Neurological Disorder Diagnostics market?

How will the Neurological Disorder Diagnostics market drivers and restraints affect the market dynamics? What forces will shape the Neurological Disorder Diagnostics industry going forward?

The Neurological Disorder Diagnostics market major growth driver - Rising Alzheimer's Prevalence Fuels Growth in Neurological Disorder Diagnostics Market. For further insights on the Neurological Disorder Diagnostics market, request a sample here

What is the forecast market size or the forecast market value of the Neurological Disorder Diagnostics market?

The Neurological Disorder Diagnostics market size has grown strongly in recent years. The neurological disorder diagnostics market size has grown strongly in recent years. It will grow from $11.75 $ billion in 2024 to $12.61 $ billion in 2025 at a compound annual growth rate (CAGR) of 7.3%. The growth in the historic period can be attributed to increase in prevalence of neurological disorders, increase in ageing population, growth in emphasis on early diagnosis and disease management, growth in awareness of neurological disorders, and increase focus on early diagnosis. The neurological disorder diagnostics market size is expected to see strong growth in the next few years. It will grow to $16.6 $ billion in 2029 at a compound annual growth rate (CAGR) of 7.1%. The growth in the forecast period can be attributed to growing awareness and education, increasing healthcare expenditure, improved access to healthcare services, expansion of diagnostic centers, and rising adoption of personalized medicine. Major trends in the forecast period include advancements in neuroimaging techniques, adoption of wearable devices and remote monitoring technologies, advancements in biomarker discovery and genetic testing, integration of artificial intelligence and machine learning, and development of point-of-care diagnostic devices. For further insights on the Neurological Disorder Diagnostics market, request a sample here

How is the Neurological Disorder Diagnostics market segmented?

The neurological disorder diagnosticsmarket covered in this report is segmented –
1) By Component: Instruments, Reagents, Kits, Software, Services
2) By Technology: Immunoassay, Polymerase Chain Reaction (PCR) Techniques
3) By Disease Type: Alzheimer's Disease, Dementia, Parkinson's Disease, Epilepsy, Traumatic Brain Injury, Other Disease Types
4) By End User: Hospitals And Clinics, Diagnostic Centers, Academic And Research Institutes
Subsegments:
1) By Instruments: Electroencephalography (EEG) Machines, Magnetic Resonance Imaging (MRI) Machines, Computed Tomography (CT) Scanners, Positron Emission Tomography (PET) Scanners, Lumbar Puncture Equipment, Ultrasound Devices, Neurostimulation Devices, Transcranial Magnetic Stimulation (TMS) Devices,
2) By Reagents: Biochemical Reagents, Antibodies, DNA Probes, RNA Probes, Enzyme-linked Immunosorbent Assay (ELISA) Reagents, Polymerase Chain Reaction (PCR) Reagents, Sample Collection Reagents
3) By Kits: Diagnostic Test Kits, Genetic Testing Kits, Biomarker Detection Kits, Immunoassay Kits, Point-of-Care Testing Kits, Screening Kits for Neurological Disorders
4) By Software: Diagnostic Software for Imaging Analysis, Data Management Software, Clinical Decision Support Software, Patient Management Software, Laboratory Information Management Systems (LIMS), Neuroinformatics Software, Telemedicine Software
5) By Services: Diagnostic Testing Services, Consultation Services, Training and Support Services, Maintenance and Repair Services for Equipment, Telehealth Services, Data Analysis Services, Research and Development Services For further insights on the Neurological Disorder Diagnostics market, request a sample here

Which region has the largest share of the Neurological Disorder Diagnostics market? What are the other regions covered in the report?

North America was the largest region in the neurological disorder diagnostics market in 2024. The regions covered in the neurological disorder diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Neurological Disorder Diagnostics market, request a sample here.

Who are the major players in the Neurological Disorder Diagnostics market?

What are the key trends in the Neurological Disorder Diagnostics market?

Major trends in the Neurological Disorder Diagnostics market include Innovative Neurological Disease Quantification Software Transforming Diagnostics Worldwide. For further insights on the Neurological Disorder Diagnostics market, request a sample here.

What are the major opportunities in the Neurological Disorder Diagnostics market? What are the strategies for the Neurological Disorder Diagnostics market?

For detailed insights on the major opportunities and strategies in the Neurological Disorder Diagnostics market, request a sample here.

How does the Neurological Disorder Diagnostics market relate to the overall economy and other similar markets?

For detailed insights on Neurological Disorder Diagnostics's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Neurological Disorder Diagnostics industry?

For detailed insights on the mergers and acquisitions in the Neurological Disorder Diagnostics industry, request a sample here.

What are the key dynamics influencing the Neurological Disorder Diagnostics market growth? SWOT analysis of the Neurological Disorder Diagnostics market.

For detailed insights on the key dynamics influencing the Neurological Disorder Diagnostics market growth and SWOT analysis of the Neurological Disorder Diagnostics industry, request a sample here.